Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in Facts
| Autor: | Catherine I. Starner, Patrick P. Gleason |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Cost-Benefit Analysis media_common.quotation_subject MEDLINE Pharmaceutical Science Pharmacy Prime (order theory) Muscular Atrophy Spinal 03 medical and health sciences 0302 clinical medicine medicine Humans Conversation 030212 general & internal medicine Psychiatry media_common business.industry 030503 health policy & services Health Policy Commerce Spinal muscular atrophy medicine.disease Manag care Models Economic 0305 other medical science business Value (mathematics) |
| Zdroj: | Journal of Managed Care & Specialty Pharmacy. 25:1306-1308 |
| ISSN: | 2376-1032 2376-0540 |
| DOI: | 10.18553/jmcp.2019.25.12.1306 |
| Popis: | This article has been corrected. Please see J Manag Care Spec Pharm, 2020;26(3):336 DISCLOSURES: No funding supported the writing of this commentary. The authors are employed by Prime Therapeutics,... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|